Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies

• Discussion of the role of immunomodulatory agents to reduce the cytokine storm in severe cases of COVID-19. • Potential immunomodulatory agents currently used in the treatment of COVID-19 (chloroquine, hydroxychloroquine and tocilizumab) are discussed. • Other immunomodulatory agents with good saf...

Descripción completa

Detalles Bibliográficos
Autor principal: Zhao, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161506/
https://www.ncbi.nlm.nih.gov/pubmed/32305588
http://dx.doi.org/10.1016/j.ijantimicag.2020.105982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161506/
https://www.ncbi.nlm.nih.gov/pubmed/32305588
http://dx.doi.org/10.1016/j.ijantimicag.2020.105982

Ejemplares similares